Patricia Villalobos

Cluster CFO - Andean countries at Pearl Therapeutics - Morristown, NJ, US

Patricia Villalobos's Colleagues at Pearl Therapeutics
Gunjan Singla

Regulatory Affairs Group Director

Contact Gunjan Singla

Eva Jaramillo

Director, Statistical Programming

Contact Eva Jaramillo

Carmina Garcia

REPRESENTANTE MEDICO - GOBIERNO

Contact Carmina Garcia

Leslie Santos

Executive Pharmaceutical Sales Specialist-Oncology Division

Contact Leslie Santos

Fernanda Bento

Clinical Research Manager

Contact Fernanda Bento

Fabio Deleuse

Business Unit Director

Contact Fabio Deleuse

View All Patricia Villalobos's Colleagues
Patricia Villalobos's Contact Details
HQ
650-305-2600
Location
Costa Rica
Company
Pearl Therapeutics
Patricia Villalobos's Company Details
Pearl Therapeutics logo, Pearl Therapeutics contact details

Pearl Therapeutics

Morristown, NJ, US • 100 - 249 Employees
Major Drugs

AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines.Our Purpose is to push the boundaries of science to deliver life-changing medicines. We believe the best way we can achieve our Purpose is to put science at the centre of everything we do. Science defines who we are. It is why we come to work every day and is part of our DNA. But this is only half of the story. We know that we do not have all the answers. We want to share ideas because we believe it results in better medicines. We want the way we work to be inclusive, open and collaborative. This approach runs through all that we do.We focus on three main therapy areas – Oncology, Cardiovascular & Metabolic Disease (CVMD) and Respiratory – and we are also selectively active in the areas of autoimmunity, neuroscience and infection. To put ourselves in the best position to push the boundaries of science, we seek to leverage our combination of capabilities, which encompass both small molecules and biologics, and include immunotherapies and developing innovative delivery devices that can offer choice to patients. These are reinforced by a strong focus on personalised healthcare capabilities, which aim to match medicines only to those patients who will benefit from them. Our teams also work alongside the world's leading academic and biotech research institutions to stimulate innovation and evaluate emerging technologies such as Modified RNA and CRISPR genome editing.AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. For more information, visit www.astrazeneca.com.Community Guidelines: bit.ly/2MgAcio

Respiratory product development High quality therapies for COPD and Asthma B2B Major Drugs Pharmaceutical Preparations Pharmaceuticals
Details about Pearl Therapeutics
Frequently Asked Questions about Patricia Villalobos
Patricia Villalobos currently works for AstraZeneca.
Patricia Villalobos's role at AstraZeneca is Cluster CFO - Andean countries.
Patricia Villalobos's email address is ***@astrazeneca.com. To view Patricia Villalobos's full email address, please signup to ConnectPlex.
Patricia Villalobos works in the Pharmaceuticals industry.
Patricia Villalobos's colleagues at Pearl Therapeutics are Gunjan Singla, Eva Jaramillo, Carmina Garcia, Predrag Marinkovic, Leslie Santos, Fernanda Bento, Fabio Deleuse and others.
Patricia Villalobos's phone number is 650-305-2600
See more information about Patricia Villalobos